DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report) – Leerink Partnrs cut their Q3 2025 earnings per share (EPS) estimates for DENTSPLY SIRONA in a report issued on Tuesday, October 14th. Leerink Partnrs analyst M. Cherny now forecasts that the medical instruments supplier will post earnings of $0.43 per share for the quarter, down from their prior estimate of $0.45. The consensus estimate for DENTSPLY SIRONA’s current full-year earnings is $1.84 per share. Leerink Partnrs also issued estimates for DENTSPLY SIRONA’s Q4 2025 earnings at $0.46 EPS, FY2025 earnings at $1.83 EPS and FY2026 earnings at $1.97 EPS.
DENTSPLY SIRONA (NASDAQ:XRAY – Get Free Report) last posted its quarterly earnings data on Thursday, August 7th. The medical instruments supplier reported $0.52 EPS for the quarter, topping analysts’ consensus estimates of $0.50 by $0.02. The business had revenue of $936.00 million for the quarter, compared to analyst estimates of $929.67 million. DENTSPLY SIRONA had a positive return on equity of 16.33% and a negative net margin of 25.85%.The firm’s revenue for the quarter was down 4.9% on a year-over-year basis. During the same period in the previous year, the company posted $0.49 earnings per share. DENTSPLY SIRONA has set its FY 2025 guidance at 1.800-2.000 EPS.
View Our Latest Analysis on XRAY
DENTSPLY SIRONA Trading Up 2.6%
Shares of XRAY opened at $12.80 on Wednesday. DENTSPLY SIRONA has a 12-month low of $11.69 and a 12-month high of $24.86. The company has a quick ratio of 1.11, a current ratio of 1.69 and a debt-to-equity ratio of 1.13. The firm has a market capitalization of $2.55 billion, a price-to-earnings ratio of -2.70, a P/E/G ratio of 0.78 and a beta of 0.96. The stock’s 50-day moving average price is $13.41 and its 200 day moving average price is $14.55.
Institutional Investors Weigh In On DENTSPLY SIRONA
Large investors have recently modified their holdings of the stock. Mirae Asset Global Investments Co. Ltd. bought a new stake in shares of DENTSPLY SIRONA in the 1st quarter valued at approximately $25,000. Trust Co. of Toledo NA OH acquired a new position in shares of DENTSPLY SIRONA in the 2nd quarter worth approximately $27,000. Parkside Financial Bank & Trust boosted its holdings in shares of DENTSPLY SIRONA by 620.6% in the 2nd quarter. Parkside Financial Bank & Trust now owns 1,715 shares of the medical instruments supplier’s stock worth $27,000 after acquiring an additional 1,477 shares in the last quarter. Brooklyn Investment Group acquired a new position in shares of DENTSPLY SIRONA in the 1st quarter worth approximately $26,000. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. acquired a new position in shares of DENTSPLY SIRONA in the 1st quarter worth approximately $26,000. 95.70% of the stock is currently owned by institutional investors.
DENTSPLY SIRONA Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Friday, October 10th. Stockholders of record on Friday, September 26th were paid a $0.16 dividend. This represents a $0.64 annualized dividend and a dividend yield of 5.0%. The ex-dividend date was Friday, September 26th. DENTSPLY SIRONA’s dividend payout ratio is currently -13.50%.
DENTSPLY SIRONA Company Profile
DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.
Further Reading
- Five stocks we like better than DENTSPLY SIRONA
- What Are the U.K. Market Holidays? How to Invest and Trade
- Palantir’s New Healthcare Deal Boosts AI and Data Reach
- Growth Investing: Should You Adopt This Investing Strategy in 2022?
- GM’s Billion-Dollar Bruise: GM’s Strategic Pivot Makes It a Buy
- How to Use the MarketBeat Excel Dividend Calculator
- Novo Nordisk’s Akero Therapeutics Buy Targets Eli Lilly’s Lead
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.